Loading clinical trials...
Loading clinical trials...
A Multicenter, Prospective, Active Controlled, Real World, Phase 4 Study of EXPAREL in Multimodal Regimens Compared With Standard of Care for Postsurgical Pain Management in Subjects Undergoing Lumbar Posterior Spine Surgeries (FUSION)
Conditions
Interventions
EXPAREL and Bupivacaine
Standard of Care
Locations
12
United States
Yale School of Medicine
New Haven, Connecticut, United States
Marcus Neuroscience Institute
Boca Raton, Florida, United States
University of Miami
Miami, Florida, United States
NorthShore University HealthSystem
Evanston, Illinois, United States
The Orthopaedic Institute of Western Kentucky
Paducah, Kentucky, United States
Bronson Methodist Hospital
Kalamazoo, Michigan, United States
Start Date
July 31, 2019
Primary Completion Date
August 4, 2020
Completion Date
August 4, 2020
Last Updated
November 9, 2021
NCT07327463
NCT07186426
NCT07231926
NCT07145619
NCT06633068
NCT07369544
Lead Sponsor
Pacira Pharmaceuticals, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions